Reuters
Regulators in the United States have been seeking overseas sources of flu vaccine after losing almost half the country's anticipated supply in October, when Chiron, one of two major makers, lost the license for its British plant because of contamination problems.
The Emeryville, Calif. company said on Tuesday that the Medicines and Healthcare Products Regulatory Agency (MHRA) has notified it that the latest suspension is not a result of new safety issues at the Liverpool plant.
More...
|